Attached files

file filename
EX-99.1 - NEWS RELEASE - CAREFUSION Corpdex991.htm
EX-99.2 - SLIDE PRESENTATION - CAREFUSION Corpdex992.htm
EX-99.3 - INFORMATION DISCLOSED BY CAREFUSION CORPORATION - CAREFUSION Corpdex993.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): November 5, 2009

 

 

CareFusion Corporation

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware

(State or Other Jurisdiction

of Incorporation)

 

001-34273   26-4123274
(Commission File Number)   (IRS Employer Identification Number)

3750 Torrey View Court, San Diego, California 92130

(Address of Principal Executive Offices, Including Zip Code)

(858) 617-2000

(Registrant’s Telephone Number, Including Area Code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 2.02 Results of Operations and Financial Condition

On November 5, 2009, CareFusion Corporation (the “Company”) issued a news release announcing its results for the quarter ended September 30, 2009. A copy of the news release is included as Exhibit 99.1 to this report.

A discussion of the reasons why management believes that the presentation of non-GAAP financial measures provides useful information to investors regarding the Company’s financial condition and results of operations is included as Exhibit 99.3 to this report.

 

Item 7.01 Regulation FD Disclosure

During a conference call scheduled to be held at 8:30 a.m. EST on November 5, 2009, the Company’s Chairman and Chief Executive Officer and Chief Financial Officer will discuss the Company’s results for the quarter ended September 30, 2009. The slide presentation for the conference call is included as Exhibit 99.2 to this report.

 

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits

 

Exhibit

No.

 

Description of Exhibit

99.1   News release issued by CareFusion Corporation on November 5, 2009 announcing first quarter results*
99.2   Slide presentation*
99.3   Information disclosed by CareFusion Corporation on November 5, 2009*

 

* Filed herewith.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

      CareFusion Corporation
      (Registrant)
Date: November 5, 2009     By:   /s/    JOAN STAFSLIEN        
      Name:   Joan Stafslien
      Title:   Executive Vice President, General Counsel and Secretary


EXHIBIT INDEX

 

Exhibit

No.

  

Description of Exhibit

99.1    News release issued by CareFusion Corporation on November 5, 2009 announcing first quarter results*
99.2    Slide presentation*
99.3    Information disclosed by CareFusion Corporation on November 5, 2009*

 

* Filed herewith.